# Sanofi: Form 20-F for the period ended Dec 31, 2018

- Company: [Sanofi](/companies/sny.md) (CIK 1121404)
- Form: 20-F
- Filed: 2019-03-08
- Accepted by EDGAR: Mar 8, 2019, 14:30 ET
- Period: 2018-12-31
- Accession: 0001193125-19-068926
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/d614161d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2018-01-01 to 2018-12-31 | EUR 11.44bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2018-01-01 to 2018-12-31 | EUR 24.24bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | EUR 4.68bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | EUR 481.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | EUR 4.31bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | EUR 3.43 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | EUR 3.45 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | EUR 5.55bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2018-12-31 | EUR 6.92bn | ifrs-full:CashAndCashEquivalents |
| Total assets | at 2018-12-31 | EUR 111.41bn | ifrs-full:Assets |
| Shareholders' equity | at 2018-12-31 | EUR 58.88bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2018-12-31 | 1,245,454,385 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/d614161d20f.htm

Filed Mar 8, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-068926. Last ingested by Listed: Nov 5, 2026, 12:26 ET. No prices; not investment advice.
